ConvaTec Group Operating Income Over Time
| 2CV Stock | EUR 2.64 0.02 0.76% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ConvaTec Group Performance and ConvaTec Group Correlation. ConvaTec |
Cross Equities Operating Income Analysis
Compare ConvaTec Group PLC and related stocks such as Cerence, TELES Informationstech, and BIOTIME Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0S6 | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 38.9 M | 65.7 M | 38.3 M | (15.3 M) | 46.3 M | 13.1 M | 11.8 M | 11.2 M |
| TLIK | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (329 K) | (2.1 M) | 4.8 M | (98.1 K) | (258.8 K) | (1.5 M) | (1.7 M) | (418.7 K) | (376.8 K) | (395.6 K) |
| BT3 | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (40.7 M) | (41 M) | (38.9 M) | (26.4 M) | (49.2 M) | (22.5 M) | (24.7 M) | (21.5 M) | (24.7 M) | (25.9 M) |
| MS9 | 439.5 B | 439.5 B | 439.5 B | 439.5 B | 244.7 B | 69.4 B | (55.4 B) | 91.9 B | 29 B | 28.5 B | (9.6 B) | (48.4 B) | (183.3 B) | (214.7 B) | (70.8 B) | (63.7 B) | (60.5 B) |
| IB5A | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (443.9 M) | (489.2 M) | (364.1 M) | (234.4 M) | (308.6 M) | (325.8 M) | (427.8 M) | (409.7 M) | (471.2 M) | (494.7 M) |
| MBJ | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (305.1 M) | (320.4 M) |
| MBJ | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (305.1 M) | (320.4 M) |
| TZO | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1 M) | (9.9 M) | (1.1 M) | (1.3 M) | (1 M) | (800.8 K) | (780.8 K) | (1.4 M) | (1.2 M) | (1.2 M) | (1.1 M) | (1.3 M) | (1.3 M) |
| AJW | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (3.3 B) | (3.1 B) | (3.3 B) | (5.6 B) | (15.6 B) | (16.3 B) | (12 B) | (9.1 B) | (8.2 B) | (8.6 B) |
| 9R5 | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (19.1 M) | (10.9 M) | (9.2 M) | (8.2 M) | (8.7 M) |
ConvaTec Group PLC and related stocks such as Cerence, TELES Informationstech, and BIOTIME Operating Income description
Operating Income is the amount of profit realized from ConvaTec Group PLC operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of ConvaTec Group PLC is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| ConvaTec Group PLC | 2CV |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 20 Eastbourne Terrace, |
| Exchange | Frankfurt Exchange |
EUR 2.64
Other Information on Investing in ConvaTec Stock
ConvaTec Group financial ratios help investors to determine whether ConvaTec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ConvaTec with respect to the benefits of owning ConvaTec Group security.